Assessing the prognostic value of IMDC risk score for nivolumab-treated patients with renal cancer and malignant melanoma
{{output}}
Background: The response of Renal Cell Cancer (RCC) to tyrosine kinase inhibitors (TKI) has been well established. Although these stratifications have been established for TKI response and prognosis, these parameters have recentl... ...
